首页|经鼻高流量湿化氧疗在慢性阻塞性肺疾病急性加重期患者的应用价值

经鼻高流量湿化氧疗在慢性阻塞性肺疾病急性加重期患者的应用价值

扫码查看
目的 探讨经鼻高流量湿化氧疗(HFNC)对慢性阻塞性肺疾病急性加重期(AECOPD)患者的疗效及适用条件。方法 回顾性分析中山市小榄人民医院呼吸内科 2021 年 1 月~2022 年 12 月收治并好转出院的 60 例AECOPD患者的临床资料,所有患者均在抗感染、止咳化痰、平喘等治疗的基础上,给予呼吸支持治疗。按照呼吸支持治疗方式不同分为HFNC组(30 例)与无创正压通气(NPPV)组(30 例)。比较两组患者生命体征(心率、呼吸)、血气分析[氧分压(PaO2)、氧合指数(PaO2/FiO2)]情况。根据年龄及PaO2/FiO2 分层,分析HFNC组患者血气分析指标的变化情况。结果 治疗前,两组患者心率、呼吸次数、PaO2、PaO2/FiO2 组间比较,差异无统计学意义(P>0。05)。治疗后,两组患者心率、呼吸次数、PaO2、PaO2/FiO2组间比较,差异无统计学意义(P>0。05);HFNC组治疗前后心率、PaO2、PaO2/FiO2 比较[(85。47±13。21)次/min vs。(97。67±22。62)次/min、(95。92±27。33)mmHg vs。(80。3±19。02)mmHg、(321。23±78。73)mmHg vs。(278。40±67。21)mmHg],差异有统计学意义(P<0。05);NPPV组治疗前后心率、呼吸次数、PaO2、PaO2/FiO2 比较[(90。33±12。02)次/min vs。(105。70±22。03)次/min、(20。67±0。76)次/min vs。(24。93±2。45)次/min、(91。54±34。81)mmHg vs。(70。86±24。03)mmHg、(311。03±113。14)mmHg vs。(240。53±86。28)mmHg],差异有统计学意义(P<0。05)。根据年龄及PaO2/FiO2 分层,与治疗前比较,HFNC组患者年龄≥71 岁、PaO2/FiO2 在 201~300 mmHg之间的患者治疗后PaO2、PaO2/FiO2 明显上升,差异有统计学意义(P<0。05)。结论 HFNC及NPPV均可改善AECOPD患者的氧合功能,效果相当,可作为NPPV的备选方案。HFNC尤其适用于年龄 71 岁及以上、PaO2/FiO2 在 201~300 mmHg的人群。
Application of high-flow nasal cannula oxygen therapy in patients with acute exacerbations of chronic obstructive pulmonary disease
Objective To explore the value of HFNC in patients with AECOPD.Methods A retrospective analysis was conducted on the clinical data of 66 AECOPD patients admitted and discharged from the respiratory department of Xiaolan People's Hospital from January 2021 to December 2022.All patients received respiratory support treatment on the basis of anti infection,cough relieving,phlegm resolving,and asthma relieving treatments.According to different respiratory support treatment method,they were divided into HFNC group(30 cases)and NPPV group(30 cases).Compare the vital signs,blood gas analysis of two groups of patients.The changes in blood gas analysis indicators of patients in the HFNC group were stratified based on age and oxygenation index.Results There was no statistically significant difference in heart rate,respiratory frequency,oxygen partial pressure,and oxygenation index between the two groups before treatment(P>0.05).There was no statistically significant difference in heart rate,respiratory frequency,oxygen partial pressure,and oxygenation index between the two groups after treatment(P>0.05).In the HFNC group,there was a statistically significant difference in heart rate,oxygen partial pressure,and oxygenation index before and after treatment(P<0.05);The NPPV group showed statistically significant differences in heart rate,respiratory frequency,oxygen partial pressure,and oxygenation index before and after treatment(P<0.05).Patients in the HFNC group were stratified based on age and oxygenation index.Compared with before treatment,patients aged 71 years and above with oxygenation index between 201~300 mmHg showed a significant increase in PaO2 and PaO2/FiO2 after treatment,with a statistically significant difference(P<0.05).Conclusion Both HFNC and NPPV can improve oxygenation function in AECOPD patients,with comparable effects and can be used as alternative options for NPPV.HFNC is particularly suitable for people aged 71 years and above,with PaO2/FiO2 between 201~300 mmHg.

High-flow nasal cannula oxygen therapyAcute exacerbation of chronic obstructive pulmonary diseaseNoninvasive positive pressure ventilation

郭泳梅、黎艳聪、张道敏

展开 >

525415 中山市小榄人民医院(中山市第五人民医院)呼吸内科

经鼻高流量湿化氧疗 慢性阻塞性肺疾病急性加重期 无创正压通气

广东省医学科学技术研究项目

C2019033

2024

中华保健医学杂志
中国人民解放军总后勤部卫生部保健局

中华保健医学杂志

CSTPCD
影响因子:0.477
ISSN:1674-3245
年,卷(期):2024.26(2)
  • 15